MEI Pharma, Inc.

Historical 13F Holders

Symbol
MEIP
CUSIP
55279B202
All holders as of
Q2 2023
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 55279B202 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Anson Funds Management LP 13D/A
3.7% 7/24/2025
Event 7/22/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2023 Q2 1 146 k $958k
2023 Q1 50 48.8 M $11.2M
2022 Q4 53 49.5 M $12.1M
2022 Q3 63 47.6 M $18.4M
2022 Q2 69 47.5 M $28.7M
2022 Q1 93 56.4 M $34.4M
2021 Q4 110 89.2 M $238M
2021 Q3 108 65.2 M $180M
2021 Q2 112 69.0 M $197M
2021 Q1 109 70.8 M $243M
2020 Q4 112 65.5 M $173M
2020 Q3 106 66.1 M $206M
2020 Q2 105 62.9 M $260M
2020 Q1 81 64.6 M $104M
2019 Q4 80 49.4 M $122M
2019 Q3 72 36.9 M $62.0M
2019 Q2 74 46.5 M $116M
2019 Q1 64 41.0 M $126M
2018 Q4 60 40.0 M $105M
2018 Q3 64 36.4 M $157M
2018 Q2 62 36.6 M $144M
2018 Q1 47 8.51 M $17.6M
2017 Q4 50 8.75 M $18.3M
2017 Q3 58 8.64 M $23.2M
2017 Q2 47 6.65 M $15.9M
2017 Q1 47 6.30 M $10.2M
2016 Q4 37 6.48 M $9.33M
2016 Q3 41 5.52 M $9.72M
2016 Q2 38 7.63 M $10.4M
2016 Q1 41 9.94 M $12.5M
2015 Q4 42 6.60 M $10.6M
2015 Q3 37 6.22 M $9.76M
2015 Q2 41 4.93 M $8.43M
2015 Q1 48 7.98 M $14.4M
2014 Q4 53 23.7 M $101M
2014 Q3 38 12.8 M $88.3M
2014 Q2 42 13.3 M $84.3M
2014 Q1 50 14.7 M $164M